OCUL
OCUL
NASDAQ · Pharmaceuticals

Ocular Therapeutix Inc

$7.14
+0.32 (+4.69%)
As of Nov 7, 1:42 AM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +694.1% upside
Low Target $44.23
Average Target $56.70
High Target $95.28
Current Price $7.14
Current
$7.14
Target
$56.70
$44.23 $56.70 avg $95.28
Scenario Analysis
Bear Case
$44.23
519.5%
Low target
Base Case
$56.70
+694.1%
Avg target
Bull Case
$95.28
+1,234.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$16.44
-56.6% from high
52-Week Low
$6.00
+19.0% from low
Target vs 52W High
$56.70
+244.9% vs high
Next Earnings Report
Nov 9, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.37
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%